在结直肠癌进化过程中,表观遗传驱动和早期免疫逃避是结直肠癌的原因
Eszter Lakatos1,2, Vinaya Gunasri3,4, Luis Zapata5
1Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK. eszter.lakatos@chalmers.se.
Nature genetics
|November 5, 2025
概括
结肠直肠癌 (CRC) 免疫逃避在瘤形成的早期开始. 表观遗传变化驱动这种免疫逃脱,从一开始就塑造了癌症的进化.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 基因组学就是基因组学.
背景情况:
- 免疫系统控制在癌症演变中至关重要,但免疫逃避的时间及其与表观基因组改变的联系尚未完全理解.
- 了解瘤免疫共同进化对于开发有效的癌症疗法至关重要.
研究的目的:
- 研究结直肠癌 (CRCs) 瘤免疫共同进化的基因组和表观基因组驱动的进化动态.
- 描述免疫逃避的时间动态及其与表观遗传修饰的关系.
主要方法:
- 利用了多区域的多原子数据集,包括基因组,转录组和染色质可访问性概况从单个腺体CRCs.
- 包含高分辨率空间分辨的新抗原测序和瘤微环境的多重成像.
主要成果:
- 实体色素可访问性改变被发现可以降低抗原呈现基因的可访问性,并使新抗原沉默.
- 在CRC形成初期观察到免疫逃逸和排除.
- 在初始阶段后,免疫编辑的内差异是最小的,主要发生在入侵部位.
结论:
- 结直肠癌中的免疫逃避遵循'大爆炸'的进化模式,在变化附近获得.
- 这种早期的免疫逃避决定了随后的癌症免疫进化.
相关概念视频
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Transduction
1.2K
Among the three main modes of HGT—transformation, conjugation, and transduction—transduction is unique in that it is mediated by bacteriophages, or bacterial viruses.Transduction occurs in two ways. Generalized transduction occurs during the lytic cycle of a bacteriophage infection. In this process, bacteriophages infect bacterial cells, replicate within them, and ultimately cause cell lysis, releasing newly assembled virions. Occasionally, random fragments of the bacterial genome...
1.2K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.6K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.6K
Metastasis
6.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.4K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Cancer Cell Migration through Invadopodia
3.2K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.2K


